Guangdong VTR Bio-Tech Co., Ltd. (SHE:300381)
China · Delayed Price · Currency is CNY 7.13
+0.08 (1.13%)
Jan 23, 2026, 3:04 PM CST
Guangdong VTR Bio-Tech Market Cap
Guangdong VTR Bio-Tech has a market cap or net worth of 3.42 billion as of January 23, 2026. Its market cap has decreased by -0.42% in one year.
Market Cap
3.42B
Enterprise Value
2.89B
Revenue
830.87M
Ranking
n/a
PE Ratio
526.92
Stock Price
7.13
Market Cap Chart
Since January 28, 2014, Guangdong VTR Bio-Tech's market cap has increased from 1.84B to 3.42B, an increase of 86.14%. That is a compound annual growth rate of 5.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 3.39B | 8.13% |
| Dec 31, 2025 | 3.13B | -7.12% |
| Dec 31, 2024 | 3.37B | -4.55% |
| Dec 29, 2023 | 3.53B | -4.20% |
| Dec 30, 2022 | 3.69B | -36.63% |
| Dec 31, 2021 | 5.82B | 9.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Shen Lian Biomedical | 4.01B |
| Qingdao Vland Biotech INC. | 3.93B |
| Yantai Zhenghai Biotechnology | 3.88B |
| Baolingbao Biology | 3.78B |
| Shanghai Model Organisms Center | 3.52B |
| Cabio Biotech (Wuhan) | 3.34B |
| Suzhou Fushilai Pharmaceutical | 3.31B |
| Novoprotein Scientific | 3.20B |